C2N Diagnostics, LLC
Biotechnology company · St. Louis, Missouri, United States
C2N Diagnostics, LLC is a biotechnology company headquartered in St. Louis, Missouri, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3.1 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2025.
C2N Diagnostics at a glance
What does C2N Diagnostics do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3.1 million in total (2009 to 2019). NIH funding came from the National Institute on Aging.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $10 million sold (2025).
Frequently asked questions about C2N Diagnostics
Where is C2N Diagnostics headquartered?
C2N Diagnostics, LLC is headquartered in St. Louis, Missouri, United States.
What does C2N Diagnostics do?
C2N Diagnostics, LLC is a biotechnology company.
Similar companies
- MediBeacon Inc.St. Louis, Missouri, United States
- Pulse Therapeutics, Inc.St. Louis, Missouri, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.